Tarveda Therapeutics is discovering and developing a new class of potent and selective precision oncology medicines for the treatment of patients with various solid tumor malignancies. Our strategy includes developing our own proprietary Pentarin miniature conjugates to enhance the effectiveness of promising anti-cancer payloads that have struggled without their selective targeting to solid tumors.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.